83 results on '"Givens MD"'
Search Results
2. Virginia Tech's innovative research tackles complex diseases.
- Author
-
Ansar Ahmed S and Givens MD
- Published
- 2023
- Full Text
- View/download PDF
3. Assessing pregnancy outcomes in cow-calf operations after administration of modified-live or killed virus vaccinations at the initiation of synchronization for fixed-time AI.
- Author
-
Stewart JL, Currin J, Clark SG, Redifer T, Givens MD, and Mercadante VRG
- Subjects
- Pregnancy, Female, Cattle, Animals, Male, Pregnancy Outcome, Abortion, Veterinary, Pregnancy Rate, Insemination, Artificial veterinary, Vaccination veterinary, Estrus Synchronization methods, Progesterone pharmacology, Gonadotropin-Releasing Hormone pharmacology, Dinoprost pharmacology, Vaccines, Cattle Diseases
- Abstract
The objective of this study was to compare the reproductive outcomes (artificial insemination [AI] pregnancy rates, season pregnancy rates, AI pregnancy losses) and calf traits (birth and weaning weights) after vaccination of suckled beef cows against bovine herpesvirus 1 and bovine viral diarrhea virus using commercially-available modified-live virus (MLV) or killed virus (KV) vaccine at the initiation of a fixed-time AI program. Previously-vaccinated cows (n = 2138) on 14 farms throughout Virginia were enrolled in the study during the Fall 2017 and Spring 2018 breeding seasons. Animals received a single vaccination injection at 10 d pre-breeding, corresponding with time of CIDR insertion at initiation of the 7-d CO-Synch + CIDR synchronization protocol. Cows were inseminated at a fixed time (60-66 h after removal of the CIDR insert) and subsequently turned out with bulls approximately 1 wk after insemination for a natural service. Cows treated with the MLV vaccine had greater AI pregnancy rates than cows treated with the KV vaccine during the fall (P = 0.008; 54% vs. 46%, respectively), but not during the spring breeding season (P = 0.62; 48 vs. 49%). Season pregnancy rates were greater (P = 0.01) in the fall (95-96%) than in the spring breeding season (89-90%), but were not affected by vaccine treatment (P = 0.49) or treatment by season (P = 0.30) interactions. Percentage of AI pregnancy losses was not affected by season (P = 0.85), vaccine treatment (P = 0.83), or treatment by season interactions (P = 0.68). The number of cycles it took for cows to become pregnant by natural service differed by season (P = 0.006) but not treatment (P = 0.87) or treatment by season interaction (P = 0.997). Cows treated with the MLV vaccine gave birth earlier in the calving season (8.36 ± 0.6 d) than those treated with the KV vaccine (10.31 ± 0.6 d; P = 0.02). There was a main effect of season on birth weights (P = 0.008), weaning weights (P < 0.001), and ADG at weaning (P < 0.001), but no effects of treatment (P ≥ 0.26) or treatment by season interaction (P ≥ 0.10) on any of these parameters. Overall, this study demonstrated that the administration of an MLV vaccine at 10 d before fixed-time AI did not have any adverse effects on pregnancy or calf outcomes compared with KV vaccine administration., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
4. Review: Risks of disease transmission through semen in cattle.
- Author
-
Givens MD
- Subjects
- Animals, Cattle, Male, Semen Preservation, Cattle Diseases transmission, Semen microbiology, Semen virology
- Abstract
The purpose of this paper is to review scientific evidence concerning pathogens that could potentially be transmitted via bovine semen. As a result of a careful analysis of the characteristics of infections that may cause transmission of disease through semen, effective control procedures can be identified that provide minimal constraint to the introduction of new bulls into herds for natural breeding and importation of valuable novel genetics through artificial insemination. The potential for transmission through bovine semen and corresponding effective control procedures are described for bovine herpesvirus 1, bovine viral diarrhea virus, bovine leukemia virus, lumpy skin disease virus, bluetongue virus, foot-and-mouth disease virus, and Schmallenberg virus. Brief consideration is also provided regarding the potential for transmission via semen of Tritrichomonas foetus, Campylobacter fetus venerealis, Brucella abortus, Leptospira spp., Histophilus somni, Ureaplasma diversum, Mycobacterium avium subsp. paratuberculosis, Chlamydiaceae, Mycobacterium bovis, Coxiella burnetii, Mycoplasma mycoides ssp. mycoides and Neospora caninum. Thoughtful and systematic control procedures can ensure the safety of introducing new bulls and cryopreserved semen into cattle production systems.
- Published
- 2018
- Full Text
- View/download PDF
5. Complication profile, failure to rescue, and mortality following elective endovascular aortic aneurysm repair.
- Author
-
Kauvar DS, Martin ED, Simon TE, and Givens MD
- Subjects
- Aged, Female, Humans, Male, Risk Factors, Aortic Aneurysm, Abdominal mortality, Aortic Aneurysm, Abdominal surgery, Elective Surgical Procedures, Endovascular Procedures, Failure to Rescue, Health Care statistics & numerical data, Postoperative Complications epidemiology
- Abstract
Introduction: Understanding the relationship between patient risk factors, postoperative complications, and morbidity and mortality is important when considering elective endovascular aortic aneurysm repair (E-EVAR) performed to prevent aneurysm rupture mortality. We aimed to stratify complications in E-EVAR and explore their relationship with postoperative death., Methods: E-EVAR cases from 2012 NSQIP were identified. 30-day complications were categorized as major (MAJCX) or minor (MINCX) using the Clavien-Dindo classification. Failure to rescue (FTR) was defined as death following a complication. Univariate and multivariate analyses were performed to identify associations between patient risk factors, complications, and mortality. Significance set at P < 0.05., Results: 3344 E-EVAR's were analyzed, with 155 (4.6%) MINCX, 106 (3.2%) MAJCX, and 39 (1.2%) mortality. Significant univariate risk factors differed between MINCX (preoperative dyspnea 27% vs 19%, COPD 32% vs19%, HTN 87% vs 79%, functional dependence 9% vs 3%) and MAJCX (female sex 33% vs 18%, preoperative diabetes 30% vs 17%, dyspnea 40% vs 19%, COPD 46% vs 20%, anticoagulant use 20% vs 11%, and functional dependence 13% vs 3%). 24 of 39 (62%) of deaths were preceded by a complication. FTR was more frequent following MAJCX than MINCX (16% vs 4.5%, P = 0.002), and occurred most commonly after renal failure with dialysis (33% mortality with complication), cardiac arrest (33%), septic shock (22%), and reintubation (22%). Independent predictors of MAJCX included female sex (OR 2, P = 0.001), COPD (OR 2, P = 0.009), and anticoagulant use (OR 2, P = 0.001). Mortality was independently predicted by MAJCX (OR 29, P < 0.001), MINCX (OR 8, P < 0.001), and preoperative renal failure (OR 11.6, P < 0.001)., Conclusion: The majority of deaths within 30 days following E-EVAR are preceded by a complication; both MAJCX and MINCX predict mortality. FTR is more common after MAJCX; prevention efforts should take this into account. Identified risk factors should be taken into consideration when considering E-EVAR., (Published by Elsevier Inc.)
- Published
- 2017
- Full Text
- View/download PDF
6. Prevention of abortion in cattle following vaccination against bovine herpesvirus 1: A meta-analysis.
- Author
-
Newcomer BW, Cofield LG, Walz PH, and Givens MD
- Subjects
- Abortion, Veterinary virology, Animals, Cattle, Female, Herpesviridae Infections prevention & control, Herpesvirus 1, Bovine immunology, Pregnancy, Vaccination veterinary, Vaccines, Attenuated, Vaccines, Live, Unattenuated, Abortion, Veterinary prevention & control, Herpesviridae Infections veterinary, Herpesvirus Vaccines administration & dosage
- Abstract
Bovine herpesvirus 1 is ubiquitous in cattle populations and is the cause of several clinical syndromes including respiratory disease, genital disease, and late-term abortions. Control of the virus in many parts of the world is achieved primarily through vaccination with either inactivated or modified-live viral vaccines. The purpose of this meta-analysis was to determine the cumulative efficacy of BoHV-1 vaccination to prevent abortion in pregnant cattle. Germane articles for inclusion in the analysis were identified through four online scientific databases and the examination of three review and ten primary study article reference lists. A total of 15 studies in 10 manuscripts involving over 7500 animals were included in the meta-analysis. Risk ratio effect sizes were used in random effects, weighted meta-analyses to assess the impact of vaccination. Subgroup analyses were performed based on type of vaccine, MLV or inactivated, and the type of disease challenge, experimentally induced compared to field studies. A 60% decrease in abortion risk in vaccinated cattle was demonstrated. The greatest decrease in abortion risk was seen in studies with intentional viral challenge although vaccination also decreased abortion risk in field studies. Both inactivated and modified-live viral vaccines decreased abortion risk. This meta-analysis provides quantitative support for the benefit of bovine herpesvirus 1 vaccination in the prevention of abortion., (Copyright © 2017 Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
7. Impact of a killed Tritrichomonas foetus vaccine on clearance of the organism and subsequent fertility of heifers following experimental inoculation.
- Author
-
Edmondson MA, Joiner KS, Spencer JA, Riddell KP, Rodning SP, Gard JA, and Givens MD
- Subjects
- Abortion, Veterinary immunology, Abortion, Veterinary parasitology, Animals, Cattle Diseases immunology, Cattle Diseases parasitology, Female, Male, Pregnancy, Protozoan Infections, Animal immunology, Vaccination veterinary, Abortion, Veterinary prevention & control, Cattle parasitology, Cattle Diseases prevention & control, Fertility, Protozoan Infections, Animal prevention & control, Protozoan Vaccines immunology, Tritrichomonas foetus immunology
- Abstract
Tritrichomonas foetus is a sexually transmitted reproductive pathogen of cattle that causes transient infertility, early embryonic death, metritis, pyometra, and sporadic abortions. The objective of this research was to assess the impact on reproductive health of vaccinating naïve heifers with a killed T. foetus vaccine (TrichGuard) before experimental exposure followed by breeding. A total of 40 beef heifers were randomly assigned into two treatment groups. Heifers where then vaccinated with two doses of TrichGuard or sham vaccinated with 0.9% sterile saline according to their respective groups. Sixty days following vaccination or sham vaccination, heifers were intravaginally inoculated with 2 × 10
6 organisms of a cloned isolate of T. foetus of bovine origin (CDTf-4) during synchronized estrus. Three days following inoculation of T. foetus, bulls free of T. foetus were introduced for natural breeding. Three bulls were maintained with the 40 heifers (20 vaccinated; 20 sham vaccinated) for a 49-day breeding season. Cervical mucous samples were obtained from each heifer at Day 0 and at 29 additional time points throughout the study for T. foetus culture. Pregnancy assessments were performed routinely by using transrectal palpation and ultrasonography. Pregnancies were detected in 19/20 (95%) vaccinated heifers and 14/20 (70%) sham-vaccinated heifers (P = 0.046). Only 4/20 (20%) of the sham-vaccinated heifers gave birth to a live calf compared with 10/20 (50%) of the vaccinated heifers (P = 0.048). Thus, embryonic or fetal loss was detected in 9/19 (47%) vaccinated heifers and 10/14 (71%) sham-vaccinated heifers (P = 0.153). The interval of time between inoculations with T. foetus and conceptions of pregnancies that were maintained until birth did not differ significantly between groups (vaccinated = 18.7 days; sham-vaccinated = 17.3 days; P = 0.716). The infectious challenge in this study proved to be very rigorous as a positive culture was detected from all heifers. The culture-positive results on the last culture day did not differ significantly (P = 0.115) between vaccinated heifers (63.9 days) and sham-vaccinated heifers (79.2 days). All uterine culture samples collected from the 26 nonpregnant heifers on Day 207 postinoculation did not result in the detection of T. foetus. These findings indicate that the killed, whole cell vaccine used in this study (TrichGuard) was effective in improving reproductive health evidenced by significantly reducing losses associated with T. foetus infections., (Copyright © 2016 Elsevier Inc. All rights reserved.)- Published
- 2017
- Full Text
- View/download PDF
8. Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-live viral vaccine.
- Author
-
Walz PH, Givens MD, Rodning SP, Riddell KP, Brodersen BW, Scruggs D, Short T, and Grotelueschen D
- Subjects
- Abortion, Spontaneous immunology, Abortion, Spontaneous virology, Abortion, Veterinary immunology, Abortion, Veterinary virology, Animals, Antibodies, Viral biosynthesis, Bovine Virus Diarrhea-Mucosal Disease immunology, Bovine Virus Diarrhea-Mucosal Disease virology, Cattle, Diarrhea Virus 1, Bovine Viral drug effects, Diarrhea Virus 1, Bovine Viral immunology, Diarrhea Virus 1, Bovine Viral pathogenicity, Female, Fetus, Herpesvirus 1, Bovine drug effects, Herpesvirus 1, Bovine immunology, Herpesvirus 1, Bovine pathogenicity, Immunization, Secondary, Infectious Bovine Rhinotracheitis immunology, Infectious Bovine Rhinotracheitis virology, Pregnancy, Pregnancy Complications, Infectious immunology, Pregnancy Complications, Infectious virology, Vaccines, Attenuated, Vaccines, Combined, Vaccines, Inactivated, Abortion, Spontaneous prevention & control, Abortion, Veterinary prevention & control, Bovine Virus Diarrhea-Mucosal Disease prevention & control, Infectious Bovine Rhinotracheitis prevention & control, Infectious Disease Transmission, Vertical prevention & control, Pregnancy Complications, Infectious prevention & control, Viral Vaccines administration & dosage
- Abstract
The objective of this study was to compare reproductive protection in cattle against bovine viral diarrhea virus (BVDV) and bovine herpesvirus 1 (BoHV-1) provided by annual revaccination with multivalent modified-live viral (MLV) vaccine or multivalent combination viral (CV) vaccine containing temperature-sensitive modified-live BoHV-1 and killed BVDV when MLV vaccines were given pre-breeding to nulliparous heifers. Seventy-five beef heifers were allocated into treatment groups A (n=30; two MLV doses pre-breeding, annual revaccination with MLV vaccine), B (n=30; two MLV doses pre-breeding, annual revaccination with CV vaccine) and C (n=15; saline in lieu of vaccine). Heifers were administered treatments on days 0 (weaning), 183 (pre-breeding), 366 (first gestation), and 738 (second gestation). After first calving, primiparous cows were bred, with pregnancy assessment on day 715. At that time, 24 group A heifers (23 pregnancies), 23 group B heifers (22 pregnancies), and 15 group C heifers (15 pregnancies) were commingled with six persistently infected (PI) cattle for 16days. Ninety-nine days after PI removal, cows were intravenously inoculated with BoHV-1. All fetuses and live offspring were assessed for BVDV and BoHV-1. Abortions occurred in 3/23 group A cows, 1/22 group B cows, and 11/15 group C cows. Fetal infection with BVDV or BoHV-1 occurred in 4/23 group A offspring, 0/22 group B offspring, and 15/15 group C offspring. This research demonstrates efficacy of administering two pre-breeding doses of MLV vaccine with annual revaccination using CV vaccine to prevent fetal loss due to exposure to BVDV and BoHV-1., (Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
9. Thirty-Day Outcomes after Elective Percutaneous or Open Endovascular Repair of Abdominal Aortic Aneurysms.
- Author
-
Kauvar DS, Martin ED, and Givens MD
- Subjects
- Aged, Aged, 80 and over, Aortic Aneurysm, Abdominal diagnosis, Aortic Aneurysm, Abdominal mortality, Blood Vessel Prosthesis Implantation adverse effects, Blood Vessel Prosthesis Implantation mortality, Databases, Factual, Elective Surgical Procedures, Endovascular Procedures adverse effects, Endovascular Procedures mortality, Female, Humans, Length of Stay, Male, Middle Aged, Obesity complications, Patient Selection, Postoperative Complications etiology, Risk Factors, Sex Factors, Time Factors, Treatment Outcome, United States, Aortic Aneurysm, Abdominal surgery
- Abstract
Background: Percutaneous endovascular aneurysm repair (PEVAR) has become accepted as a suitable alternative to open EVAR (OEVAR) in the treatment of abdominal aortic aneurysms (AAAs). Direct comparisons between the 2 techniques have been infrequently reported and have predominantly focused on immediate procedural outcomes. The objective of this study was to compare contemporary 30-day postoperative outcomes between successfully completed elective PEVAR and OEVAR., Methods: The 2012 National Surgical Quality Improvement Program database was queried for all elective primary AAA repairs. Procedures on ruptured AAAs and those involving adjunctive thoracic, abdominal, or extremity procedures were excluded. Cases completed with at least one surgical exposure of the femoral artery for access (OPEN) were compared with those completed without such exposure (PERC). Preoperative, intraoperative, and 30-day postoperative variables were compared using appropriate univariate statistical tests. A P value of ≤0.05 was considered significant for all comparisons., Results: A total of 1,589 (51%) OPEN and 1,533 (49%) PERC cases met inclusion and exclusion criteria. Preoperative characteristics did not differ between groups. OPEN cases took significantly longer (150 ± 69 min) than PERC cases (134 ± 65 min, P < 0.001). No significant differences were found between the groups in any postoperative occurrence, but the rate of venous thromboembolism twice as high in OPEN (16, 1.0%) than PERC cases (7, 0.5%, P = 0.07). In addition, wound complications (36, 2.3% OPEN vs. 23, 1.3% PERC, P = 0.11) were more common in OPEN cases but were diagnosed a week sooner on average in PERC cases (19 days OPEN and 12 days PERC). Median postoperative length of stay was 2 days among OPEN cases versus 1 day in PERC cases (P = 0.11). Female gender and obesity predicted wound complications in the OPEN group but not in the PERC group., Conclusions: Successfully completed PEVAR and OEVAR have similar rates of overall complications. Female gender and obesity predict wound complications in OEVAR but not in PEVAR, which appears to be a safe alternative to OEVAR. PEVAR has the advantage of shorter operative time and the potential for a shorter postoperative stay, and may offer the advantage of fewer wound complications in females and obese patients., (Published by Elsevier Inc.)
- Published
- 2016
- Full Text
- View/download PDF
10. Perspective on BVDV control programs.
- Author
-
Givens MD and Newcomer BW
- Subjects
- Animals, Cattle, Communicable Disease Control economics, Diarrhea Viruses, Bovine Viral isolation & purification, Mass Screening veterinary, United States, Bovine Virus Diarrhea-Mucosal Disease prevention & control, Communicable Disease Control organization & administration
- Abstract
Programs for control and eradication of bovine viral diarrhea virus (BVDV) are often considered prudent when the expense of a control program within a specified time frame effectively prevents loss due to disease and the expense of control does not exceed the costs associated with infection. In some geographic areas, concerns about animal welfare or desires to reduce antibiotic usage may motivate BVDV control even when control programs are associated with a lack of financial return on investment. In other geographic areas, concerns about financial return on investment may be the key motivating factor in considering implementation of BVDV control programs. Past experiences indicate that systematic, well-coordinated control programs have a clear potential for success, while voluntary control programs in cultures of distributed decision-making often result in notable initial progress that ultimately ends in dissolution of efforts. Segmentation of the cattle industry into cow-calf producers, stocker/backgrounders, and feedlot operators amplifies the distribution of decision-making regarding control programs and may result in control measures for one industry segment that are associated with significant costs and limited rewards. Though the host range of BVDV extends well beyond cattle, multiple eradication programs that focus only on testing and removal of persistently infected (PI) cattle have proven to be effective in various countries. While some individuals consider education of producers to be sufficient to stimulate eradication of BVDV, research surrounding the adoption of innovative health care procedures suggests that the process of adopting BVDV control programs has a social element. Collegial interactions and discussions may be crucial in facilitating the systematic implementation necessary to optimize the long-term success of control programs. Compulsory control programs may be considered efficient and effective in some regions; however, in a nation where individual identification of cattle remains voluntary, the likelihood of effective compulsion to control BVDV within a farm or ranch appears to be very unlikely. While currently available diagnostic tests are sufficient to support BVDV eradication via systematic, well-coordinated programs, the development of a diagnostic procedure to safely and consistently detect the gestation of a PI fetus after 5 months of gestation would be a valuable research breakthrough. This desired testing modality would allow diagnosis of PI calves, while the dam continues to provide biocontainment of the infected fetus. This development could speed the progress of control programs in achieving the goal of BVDV control and eventual eradication.
- Published
- 2015
- Full Text
- View/download PDF
11. Effect of vaccination with a multivalent modified-live viral vaccine on reproductive performance in synchronized beef heifers.
- Author
-
Walz PH, Edmondson MA, Riddell KP, Braden TD, Gard JA, Bayne J, Joiner KS, Galik PK, Zuidhof S, and Givens MD
- Subjects
- Animals, Cattle blood, Diarrhea Viruses, Bovine Viral, Dinoprost administration & dosage, Dinoprost pharmacology, Estradiol blood, Female, Gonadotropin-Releasing Hormone administration & dosage, Gonadotropin-Releasing Hormone pharmacology, Herpesviridae Infections prevention & control, Herpesvirus 1, Bovine, Pregnancy, Progesterone administration & dosage, Progesterone blood, Progesterone pharmacology, Bovine Virus Diarrhea-Mucosal Disease prevention & control, Cattle physiology, Estrus Synchronization, Herpesviridae Infections veterinary, Pregnancy Rate, Viral Vaccines immunology
- Abstract
Prebreeding vaccination should provide fetal and abortive protection against bovine viral diarrhea virus (BVDV) and bovine herpesvirus 1 (BoHV-1) but not impede reproduction when administered to cattle before estrus synchronization and breeding. The objective was to assess reproductive performance when naive beef heifers were vaccinated with modified-live viral (MLV) vaccine 2 days after unsynchronized estrus, and then revaccinated with MLV vaccine at 10 or 31 days before synchronized natural breeding. Sixty beef heifers naive to BVDV and BoHV-1 were randomly assigned to one of four treatment groups. Groups A and B (n = 20 per group) were vaccinated with MLV vaccine containing BVDV and BoHV-1 at 2 days after initial detected estrus, and then revaccinated 30 days later, which corresponded to 10 days (group A) or 31 days (group B) before synchronized natural breeding. Groups C and D (n = 10 per group) served as controls and were vaccinated with an inactivated vaccine that did not contain BVDV or BoHV-1 at the same time points as groups A and B, respectively. Estrous behavior was assessed using radio frequency technology. Estrus synchronization was performed, with initiation occurring at revaccination (groups A and C) or 21 days after revaccination (groups B and D). After synchronization, heifers were submitted to a bull breeding pasture for 45 days. At the end of the breeding period, heifers were assessed for pregnancy using ultrasonography. Progesterone concentrations were evaluated at estrus and 10 days after unsynchronized and synchronized estrus, at initial pregnancy check, and at the end of the study. All pregnant heifers in groups A and B and five pregnant heifers in group C were euthanized between 44 and 62 days of gestation and ovarian and conceptus tissues were assayed for BVDV and BoHV-1. Vaccination with MLV vaccine did not result in significant negative reproductive impact based on the duration of interestrus intervals, proportion of heifers exhibiting estrus within 5 days after synchronization, serum progesterone concentrations, pregnancy rates, and pregnancies in the first 5 days of the breeding season. Bovine viral diarrhea virus and BoHV-1 were not detected in luteal tissue, ovarian tissue, or fetal tissues. Use of MLV vaccine did not impede reproduction, when revaccination was performed at 10 or 31 days before synchronized natural breeding., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
12. Efficacy of bovine viral diarrhea virus vaccination to prevent reproductive disease: a meta-analysis.
- Author
-
Newcomer BW, Walz PH, Givens MD, and Wilson AE
- Subjects
- Abortion, Veterinary virology, Animals, Bovine Virus Diarrhea-Mucosal Disease complications, Cattle, Female, Pregnancy, Risk Assessment, Vaccination methods, Abortion, Veterinary prevention & control, Bovine Virus Diarrhea-Mucosal Disease prevention & control, Diarrhea Viruses, Bovine Viral immunology, Reproduction physiology, Vaccination veterinary
- Abstract
Bovine viral diarrhea virus (BVDV) is an important reproductive pathogen of cattle worldwide. The reproductive outcome of BVDV infection is largely dependent on the immune status of the dam and the stage of gestation at the time of infection. Potential sequelae include failure of conception, abortion, a variety of congenital malformations, and fetal infection. Vaccination is a possible tool in the control of BVDV, and there has been a recently renewed focus on providing fetal protection through vaccination. Consequently, the aim of this study was to evaluate the efficacy of BVDV vaccination to prevent reproductive disease by performing a quantitative synthesis of previously published studies. Pertinent articles to be included in the analysis were identified by performing a search in four relevant scientific databases (PubMed, CAB abstracts, National Agricultural Library catalog, and Web of Science) and examining the reference lists of 10 germane review articles. Inclusion criteria for the meta-analysis mandated that the studies were controlled, primary studies that included necessary data for use in the meta-analysis (e.g., group size, number of abortions). Forty-six studies in 41 separate articles matched the inclusion criteria. Risk ratio effect sizes were used in random effects, weighted meta-analyses to assess the impact of BVDV vaccination on three outcomes: risk of fetal infection, abortion risk, and pregnancy risk. Within each outcome, subanalyses were performed to evaluate the effect of a variety of interventions, including modified live, inactivated, polyvalent and monovalent vaccination, homologous, heterologous, or field challenge, and studies with only bovine subjects. The analysis revealed a decrease in abortions of nearly 45% and a nearly 85% decrease in fetal infection rate in cattle vaccinated for BVDV compared with unvaccinated cohorts. Additionally, pregnancy risk was increased by approximately 5% in field trials of BVDV vaccinates. This meta-analysis provides quantitative support for the benefit of vaccination in the prevention of BVDV-associated reproductive disease., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
13. Laboratory diagnosis and transmissibility of bovine viral diarrhea virus from a bull with a persistent testicular infection.
- Author
-
Newcomer BW, Toohey-Kurth K, Zhang Y, Brodersen BW, Marley MS, Joiner KS, Zhang Y, Galik PK, Riddell KP, and Givens MD
- Subjects
- Animals, Cattle, Diarrhea Virus 1, Bovine Viral genetics, Female, Insemination, Artificial veterinary, Male, Polymerase Chain Reaction, Semen virology, Testicular Diseases virology, United States, Bovine Virus Diarrhea-Mucosal Disease diagnosis, Bovine Virus Diarrhea-Mucosal Disease transmission, Diarrhea Virus 1, Bovine Viral physiology, Testicular Diseases veterinary
- Abstract
Recently, in the United States, a dairy bull was diagnosed as the second confirmed case of persistent testicular infection (PTI) with bovine viral diarrhea virus (BVDV). The first objective of this study was to evaluate the testing methodologies currently used by the artificial insemination industry in order to improve the detection of bulls with PTI. This study evaluated the impact of multiple factors ([1] sample tested, [2] sample handling, [3] assay used, and [4] assay methodology) on the sensitivity of detection of BVDV. The second objective of this study was to evaluate the transmissibility of BVDV from the bull through casual or sexual contact. Results from this study indicate that straws of semen should be transported to the diagnostic laboratory in liquid nitrogen dry shippers. PCR proved to be a more sensitive assay than virus isolation; however, certain PCR protocols exhibited greater diagnostic sensitivity than others. Insemination with cryopreserved semen from this infected bull caused viral transmission to a seronegative heifer resulting in viremia and seroconversion. After 42 months of age, the bull appeared to clear the infection. In conclusion, this bull validates that natural exposure to a 1a strain of BVDV can result in a unique PTI causing contamination of semen with detectable infectious virus. Appropriate handling and testing of samples is necessary in order to detect bulls exhibiting PTI. Additionally, PTI with BVDV may potentially be cleared after an extended duration., (Copyright © 2014 Elsevier B.V. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
14. Potential applications for antiviral therapy and prophylaxis in bovine medicine.
- Author
-
Newcomer BW, Walz PH, and Givens MD
- Subjects
- Animals, Cattle, Veterinary Medicine, Virus Diseases drug therapy, Virus Diseases virology, Antiviral Agents therapeutic use, Cattle Diseases drug therapy, Cattle Diseases virology, Virus Diseases veterinary
- Abstract
Viral disease is one of the major causes of financial loss and animal suffering in today's cattle industry. Increases in global commerce and average herd size, urbanization, vertical integration within the industry and alterations in global climate patterns have allowed the spread of pathogenic viruses, or the introduction of new viral species, into regions previously free of such pathogens, creating the potential for widespread morbidity and mortality in naïve cattle populations. Despite this, no antiviral products are currently commercially licensed for use in bovine medicine, although significant progress has been made in the development of antivirals for use against bovine viral diarrhea virus (BVDV), foot and mouth disease virus (FMDV) and bovine herpesvirus (BHV). BVDV is extensively studied as a model virus for human antiviral studies. Consequently, many compounds with efficacy have been identified and a few have been successfully used to prevent infection in vivo although commercial development is still lacking. FMDV is also the subject of extensive antiviral testing due to the importance of outbreak containment for maintenance of export markets. Thirdly, BHV presents an attractive target for antiviral development due to its worldwide presence. Antiviral studies for other bovine viral pathogens are largely limited to preliminary studies. This review summarizes the current state of knowledge of antiviral compounds against several key bovine pathogens and the potential for commercial antiviral applications in the prevention and control of several selected bovine diseases.
- Published
- 2014
- Full Text
- View/download PDF
15. Comparison of levels and duration of detection of antibodies to bovine viral diarrhea virus 1, bovine viral diarrhea virus 2, bovine respiratory syncytial virus, bovine herpesvirus 1, and bovine parainfluenza virus 3 in calves fed maternal colostrum or a colostrum-replacement product.
- Author
-
Chamorro MF, Walz PH, Haines DM, Passler T, Earleywine T, Palomares RA, Riddell KP, Galik P, Zhang Y, and Givens MD
- Subjects
- Animals, Animals, Newborn, Antibodies, Viral blood, Cattle, Cattle Diseases immunology, Enzyme-Linked Immunosorbent Assay veterinary, Female, Immunity, Maternally-Acquired immunology, Immunodiffusion veterinary, Male, Neutralization Tests veterinary, Random Allocation, Statistics, Nonparametric, Time Factors, Cattle Diseases virology, Colostrum immunology, Diarrhea Virus 1, Bovine Viral immunology, Diarrhea Virus 2, Bovine Viral immunology, Herpesvirus 1, Bovine immunology, Parainfluenza Virus 3, Bovine immunology, Respiratory Syncytial Virus, Bovine immunology
- Abstract
Colostrum-replacement products are an alternative to provide passive immunity to neonatal calves; however, their ability to provide adequate levels of antibodies recognizing respiratory viruses has not been described. The objective of this study was to compare the serum levels of IgG at 2 d of age and the duration of detection of antibodies to bovine viral diarrhea virus 1 (BVDV-1), bovine viral diarrhea virus 2 (BVDV-2), bovine respiratory syncytial virus (BRSV), bovine herpesvirus 1 (BHV-1), and bovine parainfluenza virus 3 (BPIV-3) in calves fed maternal colostrum (MC) or a colostrum replacement (CR) at birth. Forty newborn male Holstein calves were assigned to the CR or the MC group. Group CR (n = 20) received 2 packets of colostrum replacement (100 g of IgG per 470-g packet), while group MC (n = 20) received 3.8 L of maternal colostrum. Blood samples for detection of IgG and virus antibodies were collected from each calf at birth, at 2 and 7 d, and monthly until the calves became seronegative. Calves in the MC group had greater IgG concentrations at 2 d of age. The apparent efficiency of absorption of IgG was greater in the MC group than in the CR group, although the difference was not significant. Calves in the CR group had greater concentrations of BVDV neutralizing antibodies during the first 4 mo of life. The levels of antibodies to BRSV, BHV-1, and BPIV-3 were similar in the 2 groups. The mean time to seronegativity was similar for each virus in the 2 groups; however, greater variation was observed in the antibody levels and in the duration of detection of immunity in the MC group than in the CR group. Thus, the CR product provided calves with more uniform levels and duration of antibodies to common bovine respiratory viruses.
- Published
- 2014
16. Approved and experimental countermeasures against pestiviral diseases: Bovine viral diarrhea, classical swine fever and border disease.
- Author
-
Newcomer BW and Givens MD
- Subjects
- Animals, Antiviral Agents administration & dosage, Border Disease immunology, Border Disease prevention & control, Border Disease virology, Cattle, Cattle Diseases immunology, Cattle Diseases prevention & control, Cattle Diseases virology, Classical Swine Fever immunology, Classical Swine Fever prevention & control, Classical Swine Fever virology, Classical Swine Fever Virus drug effects, Classical Swine Fever Virus genetics, Classical Swine Fever Virus immunology, Diarrhea Viruses, Bovine Viral genetics, Diarrhea Viruses, Bovine Viral immunology, Swine, Viral Vaccines administration & dosage, Viral Vaccines genetics, Viral Vaccines immunology, Border Disease drug therapy, Cattle Diseases drug therapy, Classical Swine Fever drug therapy, Diarrhea Viruses, Bovine Viral drug effects
- Abstract
The pestiviruses, bovine viral diarrhea virus (BVDV), classical swine fever (CSFV) and border disease virus, are important livestock pathogens in many countries, but current vaccines do not completely prevent the spread of infection. Control of pestiviral diseases is especially difficult due to the constant viremia and viral shedding of persistently infected (PI) animals, which must be identified and eliminated to prevent disease transmission. Existing vaccines are limited by the delay between vaccination and the onset of protection, the difficulty of differentiating serologically between vaccinated and naturally infected animals and the need for broad vaccine cross-protection against diverse virus strains. Antiviral therapy could potentially supplement vaccination by providing immediate protection in the case of an outbreak. Numerous compounds with in vitro antiviral activity against BVDV have been identified through its role as a surrogate for hepatitis C virus. Fewer drugs active against CSFV have been identified, but many compounds that are effective against BVDV will likely inhibit CSFV, given their similar genomic sequences. While in vitro research has been promising, the paucity of efficacy studies in animals has hindered the commercial development of effective antiviral drugs against the pestiviruses. In this article, we summarize the clinical syndromes and routes of transmission of BVD, CSF and border disease, discuss currently approved vaccines, review efforts to develop antiviral therapies for use in outbreak control and suggest promising directions for future research., (Copyright © 2013 Elsevier B.V. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
17. Effect of treatment with a cationic antiviral compound on acute infection with bovine viral diarrhea virus.
- Author
-
Newcomer BW, Marley MS, Galik PK, Zhang Y, Riddell KP, Boykin DW, Kumar A, Kuhnt LA, Gard JA, and Givens MD
- Subjects
- Animals, Antibodies, Viral blood, Blood Urea Nitrogen, Bovine Virus Diarrhea-Mucosal Disease prevention & control, Cattle, Female, Male, Neutralization Tests veterinary, Pilot Projects, Random Allocation, Viremia immunology, Viremia virology, Antiviral Agents pharmacology, Benzimidazoles pharmacology, Bovine Virus Diarrhea-Mucosal Disease drug therapy, Diarrhea Viruses, Bovine Viral immunology, Furans pharmacology, Viremia veterinary
- Abstract
Bovine viral diarrhea virus (BVDV) is a widespread bovine pathogen capable of causing disease affecting multiple body systems. Previous studies have shown 2-(2-benzimidazolyl)-5-[4-(2-imidazolino)phenyl]furan dihydrochloride (DB772) effectively prevents BVDV infection in cell culture. The aim of this project was to assess the efficacy of DB772 for the prevention of acute BVDV infection. Four calves seronegative to BVDV were treated with DB772 and another 4 calves were treated with diluent only on the same dosing schedule. Each calf was subsequently challenged intranasally with BVDV. Virus was isolated consistently from untreated calves on days 4 to 8, while treated calves remained negative by virus isolation during this period. Azotemia was exhibited by all treated calves on day 4 resulting in the euthanasia of 1 calf on day 10 and the death of another on day 13. Virus was isolated from the 2 remaining treated calves on day 14 or 21. On day 21, both remaining treated calves and all 4 untreated calves had anti-BVDV antibody titers > 1:2048. This pilot study indicates that DB772 temporarily prevented acute disease due to BVDV, but carries a significant concern of renal toxicity.
- Published
- 2013
18. Mutations induced in the NS5B gene of bovine viral diarrhea virus by antiviral treatment convey resistance to the compound.
- Author
-
Newcomer BW, Neill JD, Marley MS, Ridpath JF, and Givens MD
- Subjects
- Animals, Antiviral Agents pharmacology, Benzimidazoles pharmacology, Cattle, Cattle Diseases drug therapy, DNA Mutational Analysis, Diarrhea Virus 1, Bovine Viral drug effects, Diarrhea Virus 1, Bovine Viral isolation & purification, Furans pharmacology, Molecular Sequence Data, Mutation, Missense, Pestivirus Infections drug therapy, RNA, Viral genetics, Selection, Genetic, Sequence Analysis, DNA, Antiviral Agents therapeutic use, Benzimidazoles therapeutic use, Cattle Diseases virology, Diarrhea Virus 1, Bovine Viral genetics, Drug Resistance, Viral, Furans therapeutic use, Pestivirus Infections virology, Viral Nonstructural Proteins genetics
- Abstract
Bovine viral diarrhea virus (BVDV) is a widespread bovine pathogen for which there is no specific therapeutic agent. A previous study using 2-(2-benzimidazolyl)-5-[4-(2-imidazolino)phenyl]furan dihydrochloride (DB772) to treat calves persistently infected with BVDV resulted in a decrease in the viral load of infected calves but treatment resulted in the rapid selection of drug-resistant mutant isolates. In this article we describe three mutations found in the mutant isolates associated with in vivo and in vitro resistance to DB772. All three mutations are found in the NS5B which functions as the RNA-dependent-RNA-polymerase during viral replication. Growth curves for the mutant isolates were not largely different from those of wild-type isolates when cultured in the absence of DB772. Thus, DB772 appears to act by binding to the specified domain but binding is disrupted or inhibited by the described mutation., (Copyright © 2013 Elsevier B.V. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
19. Bovine viral diarrhea virus fetal persistent infection after immunization with a contaminated modified-live virus vaccine.
- Author
-
Palomares RA, Marley SM, Givens MD, Gallardo RA, and Brock KV
- Subjects
- Animals, Bovine Virus Diarrhea-Mucosal Disease embryology, Bovine Virus Diarrhea-Mucosal Disease immunology, Bovine Virus Diarrhea-Mucosal Disease prevention & control, Cattle, Diarrhea Virus 1, Bovine Viral isolation & purification, Female, Fetal Diseases blood, Fetal Diseases immunology, Off-Label Use, Pregnancy, Pregnancy Complications, Infectious immunology, Pregnancy Complications, Infectious prevention & control, Vaccination veterinary, Vaccines, Attenuated immunology, Viremia transmission, Viremia veterinary, Bovine Virus Diarrhea-Mucosal Disease etiology, Diarrhea Virus 1, Bovine Viral immunology, Drug Contamination, Fetal Diseases etiology, Infectious Disease Transmission, Vertical prevention & control, Infectious Disease Transmission, Vertical veterinary, Pregnancy Complications, Infectious etiology, Vaccination adverse effects, Vaccines, Attenuated adverse effects
- Abstract
The objective was to determine whether a multivalent modified-live virus vaccine containing noncytopathic bovine viral diarrhea virus (BVDV) administered off-label to pregnant cattle can result in persistently infected fetuses and to assess whether vaccinal strains can be shed to unvaccinated pregnant cattle commingling with vaccinates. Nineteen BVDV-naïve pregnant heifers were randomly assigned to two groups: cattle vaccinated near Day 77 of gestation with modified-live virus vaccine containing BVDV-1a (WRL strain), bovine herpes virus-1, parainfluenza 3, and bovine respiratory syncytial virus (Vx group; N = 10) or control unvaccinated cattle (N = 9). During the course of the study a voluntary stop-sale/recall was conducted by the manufacturer because of the presence of a BVDV contaminant in the vaccine. At Day 175 of gestation, fetuses were removed by Cesarean section and fetal tissues were submitted for virus isolation, and quantitative reverse transcription polymerase chain reaction using BVDV-1- and BVDV-2-specific probes. Nucleotide sequencing of viral RNA was performed for quantitative reverse transcription polymerase chain reaction-positive samples. Two vaccinated and two control heifers aborted their pregnancies, but their fetuses were unavailable for BVDV testing. Virus was isolated from all eight fetuses in the Vx group heifers and from 2 of 7 fetuses in the control unvaccinated heifers. Only BVDV-2 was detected in fetuses from the Vx group, and only BVDV-1 was detected in the two fetuses from the control group. Both BVDV-1 and BVDV-2 were detected in the vaccine. In conclusion, vaccination of pregnant heifers with a contaminated modified-live BVDV vaccine resulted in development of BVDV-2 persistently infected fetuses in all tested vaccinated animals. Furthermore, BVDV was apparently shed to unvaccinated heifers causing fetal infections from which only BVDV-1 was detected., (Published by Elsevier Inc.)
- Published
- 2013
- Full Text
- View/download PDF
20. Immunology of chronic BVDV infections.
- Author
-
Givens MD and Marley MS
- Subjects
- Animals, Antibodies, Viral blood, Antibodies, Viral immunology, Antigen-Presenting Cells immunology, Antigen-Presenting Cells virology, Blood-Brain Barrier immunology, Blood-Brain Barrier virology, Bovine Virus Diarrhea-Mucosal Disease blood, Bovine Virus Diarrhea-Mucosal Disease virology, Cattle, Central Nervous System immunology, Central Nervous System virology, Chronic Disease, Diarrhea Viruses, Bovine Viral physiology, Female, Host-Pathogen Interactions immunology, Immune System virology, Male, Ovary immunology, Ovary virology, Testis immunology, Testis virology, Time Factors, Bovine Virus Diarrhea-Mucosal Disease immunology, Diarrhea Viruses, Bovine Viral immunology, Immune System immunology, Immunity, Cellular immunology
- Abstract
Bovine viral diarrhea virus can maintain prolonged infections within immunoprivileged sites after an otherwise transient infection of a cow, calf, or bull. Various sites provide unique niches for viral replication which are not susceptible to the complete surveillance commonly provided by the bovine immune system. Evidence indicates that pestiviral infections may be significantly prolonged within ovarian tissue, testicular tissue, central nervous system tissue, and circulating white blood cells. Within avascular portions of the ovarian follicle, granulosa cells and oocytes may maintain BVDV infections which cannot be attacked by cell-mediated immunity. When infections occur within seminiferous tubules in testicular tissue, similar protection from the immune system is provided for BVDV by the blood-testes barrier. Likewise, the blood-brain barrier has been hypothesized to provide protection for BVDV in a case involving neuropathology associated with immunohistochemical detection of BVDV. Furthermore, infections of circulating white blood cells may perturb their stimulation of an adaptive immune response and facilitate chronic infection of these cells. Thus, BVDV has demonstrated an ability to maintain prolonged viral infections in immunoprivileged sites within its natural host. The role of chronic infections in maintaining and disseminating BVDV within the cattle population and heterologous host species remains to be fully understood., (Copyright © 2012 The International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
21. Efficacy of an antiviral compound to inhibit replication of multiple pestivirus species.
- Author
-
Newcomer BW, Marley MS, Ridpath JF, Neill JD, Boykin DW, Kumar A, and Givens MD
- Subjects
- Animals, Antiviral Agents toxicity, Benzimidazoles toxicity, Cattle, Cell Line, Cell Survival drug effects, Furans toxicity, Microbial Sensitivity Tests, Pestivirus physiology, Antiviral Agents pharmacology, Benzimidazoles pharmacology, Furans pharmacology, Pestivirus drug effects, Virus Replication drug effects
- Abstract
Pestiviruses are economically important pathogens of livestock. An aromatic cationic compound (DB772) has previously been shown to inhibit bovine viral diarrhea virus (BVDV) type 1 in vitro at concentrations lacking cytotoxic side effects. The aim of this study was to determine the scope of antiviral activity of DB772 among diverse pestiviruses. Isolates of BVDV 2, border disease virus (BDV), HoBi virus, pronghorn virus and Bungowannah virus were tested for in vitro susceptibility to DB772 by incubating infected cells in medium containing 0, 0.006, 0.01, 0.02, 0.05, 0.1, 0.2, 0.39, 0.78, 1.56, 3.125, 6.25, 12.5 or 25μM DB772. The samples were assayed for the presence of virus by virus isolation and titration (BDV and BVDV 2) or PCR (HoBi, pronghorn and Bungowannah viruses). Cytotoxicity of the compound was assayed for each cell type. Complete inhibition of BVDV 2, BDV, and Pronghorn virus was detected when DB772 was included in the culture media at concentrations of 0.20μM and higher. In two of three tests, a concentration of 0.05μM DB772 was sufficient to completely inhibit HoBi virus replication. Bungowannah virus was completely inhibited at a concentration of 0.01μM DB772. Thus, DB772 effectively inhibits all pestiviruses studied at concentrations >0.20μM. As cytotoxicity is not evident at these concentrations, this antiviral compound potentially represents an effective preventative or therapeutic for diverse pestiviruses., (Copyright © 2012 Elsevier B.V. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
22. Reproductive and economic impact following controlled introduction of cattle persistently infected with bovine viral diarrhea virus into a naive group of heifers.
- Author
-
Rodning SP, Givens MD, Marley MS, Zhang Y, Riddell KP, Galik PK, Hathcock TL, Gard JA, Prevatt JW, and Owsley WF
- Subjects
- Animals, Antibodies, Viral blood, Bovine Virus Diarrhea-Mucosal Disease economics, Breeding economics, Cattle, Cost-Benefit Analysis, Diarrhea Viruses, Bovine Viral immunology, Female, Male, Pregnancy, Pregnancy Complications, Infectious veterinary, Pregnancy Complications, Infectious virology, Seasons, Bovine Virus Diarrhea-Mucosal Disease immunology, Bovine Virus Diarrhea-Mucosal Disease prevention & control, Reproduction
- Abstract
The reproductive impact following controlled introduction of animals persistently infected (PI) with bovine viral diarrhea virus (BVDV) was evaluated in BVDV-naive heifers. Heifers were randomly allocated into two groups: an unexposed control herd (n = 34) and a herd exposed to five persistently infected (PI) animals for 7 mo, beginning 50 days before the breeding season (n = 34). Initiation of the BVDV-challenge was timed to mimic either direct contact with PI calves born in the previous calving season or accidental introduction of PI herd additions prior to the breeding season. The PI animals represented BVDV Types 1a (n = 3), 1b (n = 1) and 2 (n = 1). Two BVDV-free, seropositive bulls were used in each group for 78 days breeding seasons. In both groups, 33 of 34 heifers became pregnant, with similar distribution of fetal ages. Two heifers in each group aborted (etiology undetermined). In addition, one calf was born dead and one calf died 3 days post-partum in the BVDV-exposed group. One calf in the unexposed group died 4 mo post-partum. No calves, including the stillborn calf and the two calves that died prior to weaning, were persistently infected with BVDV. In summary, introduction of PI cattle to a group of BVDV-naive heifers 50 days prior to the breeding season did not negatively impact reproductive performance. To the contrary, the active immunity that developed following field exposure to BVDV provided effective reproductive and fetal protection during the breeding season and subsequent gestations, despite continuous exposure to PI animals until approximately midgestation. Although BVDV can have potentially devastating reproductive effects, timing of infection is a critical determinant in the outcome of a BVDV infection. A controlled breeding season with introduction of herd additions at less critical reproductive time points can mitigate the negative reproductive health consequences of BVDV., (Copyright © 2012 Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
23. Protective effects against abortion and fetal infection following exposure to bovine viral diarrhea virus and bovine herpesvirus 1 during pregnancy in beef heifers that received two doses of a multivalent modified-live virus vaccine prior to breeding.
- Author
-
Givens MD, Marley MS, Jones CA, Ensley DT, Galik PK, Zhang Y, Riddell KP, Joiner KS, Brodersen BW, and Rodning SP
- Subjects
- Animals, Breeding, Cattle, Female, Fetus virology, Male, Polymerase Chain Reaction methods, Polymerase Chain Reaction veterinary, Pregnancy, Pregnancy Rate, Viral Vaccines administration & dosage, Abortion, Veterinary prevention & control, Bovine Virus Diarrhea-Mucosal Disease prevention & control, Diarrhea Viruses, Bovine Viral immunology, Herpesvirus 1, Bovine immunology, Infectious Bovine Rhinotracheitis prevention & control, Viral Vaccines immunology
- Abstract
Objective: To determine whether administration of 2 doses of a multivalent, modified-live virus vaccine prior to breeding of heifers would provide protection against abortion and fetal infection following exposure of pregnant heifers to cattle persistently infected (PI) with bovine viral diarrhea virus (BVDV) and cattle with acute bovine herpesvirus 1 (BHV1) infection., Design: Randomized controlled clinical trial., Animals: 33 crossbred beef heifers, 3 steers, 6 bulls, and 25 calves., Procedures: 20 of 22 vaccinated and 10 of 11 unvaccinated heifers became pregnant and were commingled with 3 steers PI with BVDV type 1a, 1b, or 2 for 56 days beginning 102 days after the second vaccination (administered 30 days after the first vaccination). Eighty days following removal of BVDV-PI steers, heifers were commingled with 3 bulls with acute BHV1 infection for 14 days., Results: After BVDV exposure, 1 fetus (not evaluated) was aborted by a vaccinated heifer; BVDV was detected in 0 of 19 calves from vaccinated heifers and in all 4 fetuses (aborted after BHV1 exposure) and 6 calves from unvaccinated heifers. Bovine herpesvirus 1 was not detected in any fetus or calf and associated fetal membranes in either treatment group. Vaccinated heifers had longer gestation periods and calves with greater birth weights, weaning weights, average daily gains, and market value at weaning, compared with those for calves born to unvaccinated heifers., Conclusions and Clinical Relevance: Prebreeding administration of a modified-live virus vaccine to heifers resulted in fewer abortions and BVDV-PI offspring and improved growth and increased market value of weaned calves.
- Published
- 2012
- Full Text
- View/download PDF
24. Greater numbers of nucleotide substitutions are introduced into the genomic RNA of bovine viral diarrhea virus during acute infections of pregnant cattle than of non-pregnant cattle.
- Author
-
Neill JD, Newcomer BW, Marley SD, Ridpath JF, and Givens MD
- Subjects
- Acute Disease, Animals, Bovine Virus Diarrhea-Mucosal Disease immunology, Cattle, Cattle Diseases immunology, Cell Line, Diarrhea Viruses, Bovine Viral isolation & purification, Disease Susceptibility, Female, Mutation, Pregnancy, Pregnancy Complications, Infectious virology, Bovine Virus Diarrhea-Mucosal Disease virology, Cattle Diseases virology, Diarrhea Viruses, Bovine Viral genetics, Genetic Variation, Genome, Viral, Pregnancy Complications, Infectious veterinary, RNA, Viral chemistry
- Abstract
Background: Bovine viral diarrhea virus (BVDV) strains circulating in livestock herds show significant sequence variation. Conventional wisdom states that most sequence variation arises during acute infections in response to immune or other environmental pressures. A recent study showed that more nucleotide changes were introduced into the BVDV genomic RNA during the establishment of a single fetal persistent infection than following a series of acute infections of naïve cattle. However, it was not known if nucleotide changes were introduce when the virus crossed the placenta and infected the fetus or during the acute infection of the dam., Methods: The sequence of the open reading frame (ORF) from viruses isolated from four acutely infected pregnant heifers following exposure to persistently infected (PI) calves was compared to the sequences of the virus from the progenitor PI calf and the virus from the resulting progeny PI calf to determine when genetic change was introduced. This was compared to genetic change found in viruses isolated from a pregnant PI cow and its PI calf, and in three viruses isolated from acutely infected, non-pregnant cattle exposed to PI calves., Results: Most genetic changes previously identified between the progenitor and progeny PI viruses were in place in the acute phase viruses isolated from the dams six days post-exposure to the progenitor PI calf. Additionally, each progeny PI virus had two to three unique nucleotide substitutions that were introduced in crossing the placenta and infection of the fetus. The nucleotide sequence of two acute phase viruses isolated from steers exposed to PI calves revealed that six and seven nucleotide changes were introduced during the acute infection. The sequence of the BVDV-2 virus isolated from an acute infection of a PI calf (BVDV-1a) co-housed with a BVDV-2 PI calf had ten nucleotides that were different from the progenitor PI virus. Finally, twenty nucleotide changes were identified in the PI virus of a calf born to a PI dam., Conclusions: These results demonstrate that nucleotide changes are introduced into the BVDV infecting pregnant cattle at rates of 2.3 to 8 fold higher then during the acute infection of non-pregnant animals.
- Published
- 2012
- Full Text
- View/download PDF
25. Evaluation of the onset of protection induced by a modified-live virus vaccine in calves challenge inoculated with type 1b bovine viral diarrhea virus.
- Author
-
Palomares RA, Givens MD, Wright JC, Walz PH, and Brock KV
- Subjects
- Animals, Antibodies, Viral blood, Bovine Virus Diarrhea-Mucosal Disease virology, Cattle, Female, Immunization Schedule, Male, Vaccines, Attenuated, Bovine Virus Diarrhea-Mucosal Disease prevention & control, Diarrhea Virus 1, Bovine Viral, Viral Vaccines immunology
- Abstract
Objective: To evaluate onset of protection induced by modified-live virus (MLV) bovine viral diarrhea virus (BVDV) vaccine administered 7, 5, or 3 days before inoculation with type 1b BVDV (strain NY-1). Animals-40 calves., Procedures: Calves were assigned to 4 groups: an unvaccinated control group or groups vaccinated with MLV vaccine containing BVDV types 1a and 2 at 7, 5, or 3 days, before inoculation with NY-1 BVDV. Blood samples were collected for leukocyte counts, serum virus neutralization, and virus isolation (VI); nasal swab specimens (NSSs) were obtained for VI, and rectal temperatures were monitored for 14 days after inoculation., Results: No significant differences in leukocyte counts or rectal temperatures were detected after BVDV inoculation in vaccinated calves. Vaccinated calves had reduced viremia and viral shedding after inoculation, compared with results for unvaccinated calves. On day 5 after inoculation, a higher proportion of calves vaccinated 3 days before inoculation had positive VI from NSSs, compared with NSS VI results for calves vaccinated 5 and 7 days before inoculation. Unvaccinated calves had leukopenia on days 3, 5, and 6 and had higher rectal temperatures on days 7 and 8 after inoculation, compared with temperatures before inoculation. All unvaccinated calves had ≥ 1 positive VI result from NSSs 3 to 11 days after inoculation, and 4 became viremic., Conclusions and Clinical Relevance: MLV BVDV vaccine prevented fever, viremia, and leukopenia in calves challenge inoculated with NY-1 BVDV. A high proportion of calves vaccinated 3 days before inoculation shed BVDV after inoculation.
- Published
- 2012
- Full Text
- View/download PDF
26. Inactivation at various temperatures of bovine viral diarrhea virus in beef derived from persistently infected cattle.
- Author
-
Bratcher CL, Wilborn BS, Finegan HM, Rodning SP, Galik PK, Riddell KP, Marley MS, Zhang Y, Bell LN, and Givens MD
- Subjects
- Animals, Carrier State virology, Cattle, Chlorocebus aethiops, Female, Male, Multivariate Analysis, Vero Cells, Bovine Virus Diarrhea-Mucosal Disease virology, Carrier State veterinary, Cooking methods, Diarrhea Viruses, Bovine Viral physiology, Meat virology, Muscle, Skeletal virology, Virus Inactivation
- Abstract
Bovine viral diarrhea virus (BVDV) is a pestivirus that is enzootic in most cattle populations throughout the world. This virus is present throughout the body of persistently infected (PI) cattle. Previous research has not assessed the cooking temperature at which BVDV in meat from PI cattle can be inactivated. Therefore, muscle tissue from 6 PI cattle was harvested, refrigerated, frozen, and heated to various internal temperatures. The concentration of virus present was determined by virus isolation. Average cell culture infective doses (50% endpoint; CCID(50)) of BVDV per gram of frozen, uncooked meat from PI cattle were 10(5.85) CCID(50)/g of whole cuts and 10(6.02) CCID(50)/g of ground meat. The virus in whole and ground meat was consistently inactivated when cooked to temperatures greater than or equal to 75°C. A second objective of this research was to thoroughly reassess if Vero cells were permissive to BVDV infection in our laboratory to provide further indication of whether primates, including humans, might be susceptible to BVDV. Vero cells were not permissive to infection with any of 43 different strains of BVDV that readily replicated in Madin Darby bovine kidney cells. In conclusion, this bovine pathogen, which is not considered to be a human pathogen, can be inactivated by cooking ground or whole cuts of meat to 75°C or higher. Care should be taken to ensure that susceptible hosts such as pigs are not fed improperly cooked meat, meat by-products, or waste food originating from PI cattle.
- Published
- 2012
- Full Text
- View/download PDF
27. Antiviral treatment of calves persistently infected with bovine viral diarrhoea virus.
- Author
-
Newcomer BW, Marley MS, Galik PK, Walz PH, Zhang Y, Riddell KP, Dykstra CC, Boykin DW, Kumar A, Cruz-Espindola C, Boothe DM, Joiner KS, and Givens MD
- Subjects
- Animals, Antiviral Agents adverse effects, Antiviral Agents pharmacokinetics, Benzimidazoles adverse effects, Benzimidazoles pharmacokinetics, Cattle, Diarrhea Viruses, Bovine Viral physiology, Dose-Response Relationship, Drug, Drug Resistance, Viral drug effects, Drug Resistance, Viral physiology, Furans adverse effects, Furans pharmacokinetics, Microbial Sensitivity Tests, Osmolar Concentration, Time Factors, Antiviral Agents therapeutic use, Benzimidazoles therapeutic use, Bovine Virus Diarrhea-Mucosal Disease drug therapy, Diarrhea Viruses, Bovine Viral drug effects, Furans therapeutic use
- Abstract
Background: Animals persistently infected (PI) with bovine viral diarrhoea virus (BVDV) are a key source of viral propagation within and among herds. Currently, no specific therapy exists to treat PI animals. The purpose of this research was to initiate evaluation of the pharmacokinetic and safety data of a novel antiviral agent in BVDV-free calves and to assess the antiviral efficacy of the same agent in PI calves., Methods: One BVDV-free calf was treated with 2-(2-benzimidazolyl)-5-[4-(2-imidazolino)phenyl]furan dihydrochloride (DB772) once at a dose of 1.6 mg/kg intravenously and one BVDV-free calf was treated three times a day for 6 days at 9.5 mg/kg intravenously. Subsequently, four PI calves were treated intravenously with 12 mg/kg DB772 three times a day for 6 days and two PI control calves were treated with an equivalent volume of diluent only., Results: Prior to antiviral treatment, the virus isolated from each calf was susceptible to DB772 in vitro. The antiviral treatment effectively inhibited virus for 14 days in one calf and at least 3 days in three calves. Subsequent virus isolated from the three calves was resistant to DB772 in vitro. No adverse effects of DB772 administration were detected., Conclusions: Results demonstrate that DB772 administration is safe and exhibits antiviral properties in PI calves while facilitating the rapid development of viral resistance to this novel therapeutic agent., (© 2012 International Medical Press)
- Published
- 2012
- Full Text
- View/download PDF
28. Genetic change in the open reading frame of bovine viral diarrhea virus is introduced more rapidly during the establishment of a single persistent infection than from multiple acute infections.
- Author
-
Neill JD, Newcomer BW, Marley SD, Ridpath JF, and Givens MD
- Subjects
- Animals, Antigens, Viral immunology, Cattle, Diarrhea Virus 1, Bovine Viral immunology, Diarrhea Virus 1, Bovine Viral isolation & purification, Diarrhea Virus 2, Bovine Viral immunology, Diarrhea Virus 2, Bovine Viral isolation & purification, Molecular Sequence Data, RNA, Viral genetics, Sequence Analysis, DNA, Viral Proteins genetics, Viral Proteins immunology, Adaptation, Biological, Antigens, Viral genetics, Bovine Virus Diarrhea-Mucosal Disease virology, Diarrhea Virus 1, Bovine Viral genetics, Diarrhea Virus 2, Bovine Viral genetics, Genetic Variation, Hemorrhagic Syndrome, Bovine virology
- Abstract
Bovine viral diarrhea viruses (BVDV) are ubiquitous viral pathogens of cattle with a high degree of sequence diversity amongst strains circulating in livestock herds. The driving force behind change in sequence is not well established but the inaccurate replication of the genomic RNA by a viral RNA polymerase without proof-reading capabilities as well as immune pressure on immunodominant proteins are thought to play major roles. Additionally, it is not clear when the majority of changes are introduced, whether during acute infections with exposure to innate and adaptive immune responses or in establishment of persistent infections (PI) in utero. To examine which generates greater sequence diversity, two groups of viruses were compared. The first was six isolates of a single strain of BVDV-2 that were isolated over greater than a year's time. These viruses caused a series of severe acute (SA) BVD outbreaks over a large geographic area. Changes in nucleotide sequence were determined by comparison of the sequence of each strain to the six virus consensus sequence. The second group was composed of six BVDV strains isolated from PI calves whose dams were exposed to PI cattle. Changes were identified by comparison of the sequence of the progenitor PI virus to that of the progeny viruses from the single in vivo 'passage'. The open reading frames (ORF) of the six SA isolates were >99% identical at the nucleotide level with 30% of the changes being nonsynonymous changes. The amount of genetic change increased with time and distance from the original outbreak. Similarly, the PI viruses isolated from single passage PI calves had >99% identity with the progenitor virus. The number of nucleotide changes in these viruses was equal to or greater than that observed in the SA viruses. The majority of the nonsynonymous changes were found in the structural proteins, with 65% of these occurring in the immunodominant E2 protein. Antigenic mapping studies using a monoclonal antibody panel specific for the BVDV E2 protein showed no antigenic differences amongst the six SA viruses, nor between the progenitor and progeny type 1a and type 2 persistent viruses. However, antigenic differences were observed in the two type 1b progeny viruses that possessed the greatest number of amino acid changes. Two antibodies were found to have altered staining patterns. These results suggest that the establishment of a single persistent infection results in more rapid generation of genetic diversity in BVDV strains than a series of acute infections and may contribute to antigenic change in the absence of an immune response., (Published by Elsevier B.V.)
- Published
- 2011
- Full Text
- View/download PDF
29. Evaluation of transmission of bovine viral diarrhea virus (BVDV) between persistently infected and naive cattle by the horn fly (Haematobia irritans).
- Author
-
Chamorro MF, Passler T, Givens MD, Edmondson MA, Wolfe DF, and Walz PH
- Subjects
- Animals, Antibodies, Viral blood, Bovine Virus Diarrhea-Mucosal Disease blood, Bovine Virus Diarrhea-Mucosal Disease virology, Carrier State transmission, Carrier State virology, Cattle, Diarrhea Viruses, Bovine Viral genetics, Diarrhea Viruses, Bovine Viral immunology, Male, Neutralization Tests veterinary, RNA, Viral chemistry, RNA, Viral genetics, Random Allocation, Reverse Transcriptase Polymerase Chain Reaction veterinary, Bovine Virus Diarrhea-Mucosal Disease transmission, Carrier State veterinary, Diarrhea Viruses, Bovine Viral physiology, Muscidae virology
- Abstract
Identifying reservoirs and transmission routes for bovine viral diarrhea virus (BVDV) are important in developing biosecurity programs. The aim of this study was to evaluate BVDV transmission by the hematophagous horn fly (Haematobia irritans). Flies collected from four persistently infected cattle were placed in fly cages attached to principal (n = 4) and control (n = 4) BVDV-naïve calves housed individually in isolation rooms. Flies were able to feed on principal calves, but a barrier prevented fly feeding from control calves. Flies were tested for BVDV by RT-PCR and virus isolation at time of collection from PI cattle and after 48 h of exposure on BVDV-naïve calves. Blood samples were collected from calves and tested for BVDV infection. Virus was isolated from fly homogenates at collection from PI animals and at removal from control and principal calves. All calves remained negative for BVDV by virus isolation and serology throughout the study. Bovine viral diarrhea virus may be detected in horn flies collected from PI cattle, but horn flies do not appear to be an important vector for BVDV transmission.
- Published
- 2011
- Full Text
- View/download PDF
30. Pharmacokinetics of ketamine in plasma and milk of mature Holstein cows.
- Author
-
Sellers G, Lin HC, Riddell MG, Ravis WR, Lin YJ, Duran SH, and Givens MD
- Subjects
- Analgesics administration & dosage, Analgesics chemistry, Animals, Area Under Curve, Female, Half-Life, Ketamine administration & dosage, Ketamine chemistry, Analgesics blood, Analgesics pharmacokinetics, Cattle blood, Ketamine blood, Ketamine pharmacokinetics, Milk chemistry
- Abstract
The purpose of this study was to evaluate the pharmacokinetics of ketamine in mature Holstein cows following administration of a single intravenous (i.v.) dose. Plasma and milk concentrations were determined using a high-performance liquid chromatography assay. Pharmacokinetic parameters were estimated using a noncompartmental method. Following i.v. administration, plasma T(max) was 0.083 h and plasma C(max) was 18,135 ± 22,720 ng/mL. Plasma AUC was 4484 ± 1,398 ng·h/mL. Plasma t(½β) was 1.80 ± 0.50 h and mean residence time was 0.794 ± 0.318 h with total body clearance of 1.29 ± 0.70 L/h/kg. The mean plasma steady-state volume of distribution was calculated as 0.990 ± 0.530 L/kg and volume of distribution based on area was calculated as 3.23 ± 1.51 L/kg. The last measurable time for ketamine detection in plasma was 8.0 h with a mean concentration of 24.9 ± 11.8 ng/mL. Milk T(max) was detected at 0.67 ± 0.26 h with C(max) of 2495 ± 904 ng/mL. Milk AUC till the last time was 6593 ± 2617 ng·h/mL with mean AUC milk to AUC plasma ratio of 1.99 ± 2.15. The last measurable time that ketamine was detected in milk was 44 ± 10.0 h with a mean concentration of 16.0 ± 9.0 ng/mL., (© 2010 Blackwell Publishing Ltd.)
- Published
- 2010
- Full Text
- View/download PDF
31. Risk and prevention of bovine viral diarrhea virus (BVDV) transmission through embryo production via somatic cell nuclear transfer (SCNT) using oocytes from persistently infected donors.
- Author
-
Gregg K, Riddell KP, Chen SH, Galik PK, Xiang T, Guerra T, Marley MS, Polejaeva I, and Givens MD
- Subjects
- Animals, Cattle, Female, Follicular Fluid virology, Oocyte Donation veterinary, Polymerase Chain Reaction, RNA, Viral analysis, RNA, Viral blood, Risk Factors, Tissue and Organ Harvesting methods, Tissue and Organ Harvesting veterinary, Bovine Virus Diarrhea-Mucosal Disease prevention & control, Bovine Virus Diarrhea-Mucosal Disease transmission, Diarrhea Viruses, Bovine Viral genetics, Nuclear Transfer Techniques, Oocytes virology
- Abstract
The objective was to assess the risk of transmission of bovine viral diarrhea virus (BVDV) through embryo production via somatic cell nuclear transfer (SCNT), with oocytes obtained from persistently infected (PI) donors. Using ultrasound-guided follicular aspiration following superstimulation, oocytes were obtained from five female beef cattle, including three that were PI and two that were negative for BVDV. In the three PI cattle, seven aspirations yielded 32 oocytes (PI-1: three aspirations yielding six oocytes; PI-2: two aspirations yielding 14 oocytes; and PI-3: two aspirations yielding 12 oocytes). The oocyte recovery rate was better in negative control cattle, with 32 oocytes obtained from the two cattle in a single superstimulation and aspiration session. Oocytes were processed individually for SCNT, evaluated, and tested for BVDV. Nearly all (31/32) oocytes from the three PI donors were positive for BVDV by PCR, with detected viral RNA copy number ranging from 1 to 1.1 x 10(5). The proportion of oocytes acceptable for SCNT embryo production (based on oocyte quality and maturation status) was only 16 to 35% from PI donors, but was 81% from control donors. Therefore, routine testing of unacceptable (discarded) oocytes could be an effective approach to identify batches that might contain infected oocytes from PI donors. Identification and removal of high-risk batches of oocytes would minimize the risk of BVDV transmission through SCNT embryo production.
- Published
- 2010
- Full Text
- View/download PDF
32. Control of bovine viral diarrhea virus in ruminants.
- Author
-
Walz PH, Grooms DL, Passler T, Ridpath JF, Tremblay R, Step DL, Callan RJ, and Givens MD
- Subjects
- Animals, Bovine Virus Diarrhea-Mucosal Disease epidemiology, Cattle, United States, Bovine Virus Diarrhea-Mucosal Disease prevention & control, Diarrhea Viruses, Bovine Viral, Ruminants
- Published
- 2010
- Full Text
- View/download PDF
33. Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus.
- Author
-
Rodning SP, Marley MS, Zhang Y, Eason AB, Nunley CL, Walz PH, Riddell KP, Galik PK, Brodersen BW, and Givens MD
- Subjects
- Abortion, Veterinary prevention & control, Abortion, Veterinary virology, Animals, Animals, Newborn immunology, Bovine Virus Diarrhea-Mucosal Disease immunology, Bovine Virus Diarrhea-Mucosal Disease transmission, Bovine Virus Diarrhea-Mucosal Disease virology, Cattle, Commerce, Female, Infectious Disease Transmission, Vertical veterinary, Male, Neutralization Tests, Pregnancy, Pregnancy Complications, Infectious prevention & control, Pregnancy Complications, Infectious veterinary, Pregnancy Complications, Infectious virology, Pregnancy, Animal immunology, Vaccines, Attenuated therapeutic use, Bovine Virus Diarrhea-Mucosal Disease prevention & control, Diarrhea Viruses, Bovine Viral immunology, Vaccination veterinary, Viral Vaccines therapeutic use
- Abstract
Eighty crossbred beef heifers were randomly allocated to four groups to evaluate the efficacy of vaccination in preventing development of calves persistently infected with bovine viral diarrhea virus (BVDV). Group 1 (n=11) was non-vaccinated controls, whereas three groups were vaccinated with commercially available multivalent BVDV vaccines at weaning (approximately 7 mo of age), 28 d post-weaning, approximately 1 y of age, and 28 d later. Groups 2 (n=23) and 3 (n=23) were given a modified-live BVDV vaccine, whereas Group 4 was given an inactivated BVDV vaccine. Heifers were bred by AI and subsequently exposed to two bulls. At 61 d after AI, 70 heifers were pregnant (n=10 for Group 1 and n=20/group for Groups 2, 3, and 4). Three cattle persistently infected with BVDV were commingled with the pregnant heifers (in an isolated pasture) from 68 to 126 d after AI. Thereafter, viremias were detected in pregnant heifers from Groups 1, 3, and 4 (10/10, 1/20, and 10/20, respectively), but not in pregnant heifers from Group 2 (0/20). Resulting calves were assessed for persistent infection using serum PCR, ear notch antigen capture-ELISA, and immunohistochemistry. Persistently infected calves were only produced in Group 1 (10/10) and Group 4 (2/18). In conclusion, commercial vaccines provided effective fetal protection despite prolonged natural exposure to BVDV. Given that viremias were detected in 11 vaccinated heifers after BVDV exposure, and two vaccinated heifers gave birth to persistently infected calves, there is continued need for biosecurity and diagnostic surveillance, in addition to vaccination, to ensure effective BVDV control., ((c) 2010 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
34. Intrauterine inoculation of seronegative heifers with bovine viral diarrhea virus concurrent with transfer of in vivo-derived bovine embryos.
- Author
-
Gard JA, Givens MD, Marley MS, Galik PK, Riddell KP, Edmondson MA, and Rodning SP
- Subjects
- Abortion, Veterinary etiology, Abortion, Veterinary virology, Administration, Intravaginal, Animals, Bovine Virus Diarrhea-Mucosal Disease blood, Bovine Virus Diarrhea-Mucosal Disease pathology, Bovine Virus Diarrhea-Mucosal Disease physiopathology, Bovine Virus Diarrhea-Mucosal Disease transmission, Cattle, Cells, Cultured, Cytopathogenic Effect, Viral, Embryo Culture Techniques, Embryo Implantation physiology, Embryo Loss etiology, Embryo Loss veterinary, Embryo Loss virology, Embryo, Mammalian, Female, Male, Pregnancy, Serologic Tests veterinary, Diarrhea Viruses, Bovine Viral physiology, Embryo Transfer methods, Pregnancy, Animal, Uterus virology
- Abstract
Bovine viral diarrhea virus (BVDV) has been shown to be associated with single transferable in vivo-derived bovine embryos despite washing and trypsin treatment. Hence, the primary objective was to evaluate the potential of BVDV to be transmitted via the intrauterine route at the time of embryo transfer. In vivo-derived bovine embryos (n=10) were nonsurgically collected from a single Bos tarus donor cow negative for BVDV. After collection and washing, embryos were placed into transfer media containing BVDV (SD-1; Type 1a). Each of the 10 embryos was individually loaded into an 0.25-mL straw, which was then nonsurgically transferred into the uterus of 1 of the 10 seronegative recipients on Day 0. The total quantity of virus transferred into the uterus of each of the 10 Bos tarus recipients was 878 cell culture infective doses to the 50% end point (CCID(50))/mL. Additionally, control heifers received 1.5 x 10(6) CCID(50) BVDV/.5 mL without an embryo (positive) or heat-inactivated BVDV (negative). The positive control heifer and all 10 recipients of virus-exposed embryos exhibited viremia by Day 6 and seroconverted by Day 15 after transfer. The negative control heifer did not exhibit a viremia or seroconvert. At 30 d after embryo transfer, 6 of 10 heifers in the treatment group were pregnant; however, 30 d later, only one was still pregnant. This fetus was nonviable and was positive for BVDV. In conclusion, the quantity of BVDV associated with bovine embryos after in vitro exposure can result in viremia and seroconversion of seronegative recipients after transfer into the uterus during diestrus., ((c) 2010 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
35. Transmission of bovine viral diarrhea virus among white-tailed deer (Odocoileus virginianus).
- Author
-
Passler T, Ditchkoff SS, Givens MD, Brock KV, DeYoung RW, and Walz PH
- Subjects
- Animals, Antigens, Viral isolation & purification, Cattle, Female, Neutralization Tests, Pregnancy, Bovine Virus Diarrhea-Mucosal Disease transmission, Deer, Diarrhea Virus 1, Bovine Viral physiology, Disease Reservoirs veterinary, Infectious Disease Transmission, Vertical veterinary
- Abstract
Cattle persistently infected (PI) with bovine viral diarrhea virus (BVDV), a pestivirus in the family Flaviviridae, are an important source of viral transmission to susceptible hosts. Persistent BVDV infections have been identified in white-tailed deer (Odocoileus virginianus), the most abundant free-ranging ruminant in North America. As PI deer shed BVDV similarly to PI cattle, maintenance of BVDV within white-tailed deer populations may be possible. To date, intraspecific transmission of BVDV in white-tailed deer has not been evaluated, which prompted this study. Six pregnant white-tailed deer were captured in the first trimester of pregnancy and cohabitated with a PI white-tailed deer. Cohabitation with the PI deer resulted in BVDV infection in all does, as indicated by seroconversion. All does gave birth to live fawns and no reproductive losses were observed. At birth, evidence of BVDV infection was identified in two singlet fawns, of which one was determined to be PI by repeated serum reverse transcription nested PCR, whole blood virus isolation and immunohistochemistry. This study demonstrates for the first time that BVDV transmission may occur among white-tailed deer. The birth of a PI fawn through contact to a PI white-tailed deer indicates that under appropriate circumstances, BVDV may be maintained in white-tailed deer by congenital infection., (INRA, EDP Sciences, 2009)
- Published
- 2010
- Full Text
- View/download PDF
36. Epidemiology of prolonged testicular infections with bovine viral diarrhea virus.
- Author
-
Givens MD, Riddell KP, Edmondson MA, Walz PH, Gard JA, Zhang Y, Galik PK, Brodersen BW, Carson RL, and Stringfellow DA
- Subjects
- Animals, Bovine Virus Diarrhea-Mucosal Disease transmission, Bovine Virus Diarrhea-Mucosal Disease virology, Cattle virology, Female, Insemination, Artificial veterinary, Male, Reverse Transcriptase Polymerase Chain Reaction, Semen virology, Testicular Diseases etiology, Testicular Diseases virology, Testis pathology, Testis virology, Bovine Virus Diarrhea-Mucosal Disease complications, Diarrhea Viruses, Bovine Viral, Testicular Diseases veterinary
- Abstract
Previously, bovine viral diarrhea virus (BVDV) had been found in prolonged testicular infections following acute infection of immunocompetent bulls. The primary purpose of this research was to evaluate the production and maintenance of prolonged testicular infections after exposure to BVDV of seronegative bulls in varying circumstances. The secondary objective was to initiate assessment of the potential for transmission of BVDV via semen of bulls exhibiting a prolonged testicular infection. In total, 10 research trials were conducted. The first trial examined the duration of detectable virus in semen after intranasal inoculation of peri-pubertal bulls. The second to fifth trials examined the potential for prolonged testicular infections resulting from natural exposure of seronegative bulls to persistently infected heifers. In the last five trials, the potential for viral transmission from bulls exhibiting prolonged testicular infections to a small number of exposed animals (n=28) was evaluated. Results of this research demonstrated that prolonged testicular infections could result in detection of viral RNA in semen for 2.75 years with infectious virus grown from testicular tissue 12.5 months after viral exposure. A type 1b strain of BVDV caused prolonged testicular infection after natural exposure of seronegative bulls to a persistently infected heifer. However, transmission of BVDV to susceptible animals was not detected in the final five trials of this research. In conclusion, BVDV can persist in testicular tissue after acute infection for several years, but the potential for viral transmission from these prolonged testicular infections appears to be low.
- Published
- 2009
- Full Text
- View/download PDF
37. Pharmacokinetics of lidocaine in serum and milk of mature Holstein cows.
- Author
-
Sellers G, Lin HC, Riddell MG, Ravis WR, Duran SH, and Givens MD
- Subjects
- Analgesia, Epidural veterinary, Anesthetics, Local analysis, Anesthetics, Local blood, Animals, Cattle metabolism, Chromatography, High Pressure Liquid, Female, Lidocaine analysis, Lidocaine blood, Anesthetics, Local pharmacokinetics, Lidocaine pharmacokinetics, Milk chemistry
- Abstract
The purpose of this study was to evaluate the pharmacokinetics of lidocaine in mature Holstein cows following an inverted L and caudal epidural nerve block. Plasma and milk concentrations were determined using high-performance liquid chromatography assay. Pharmacokinetic parameters were estimated using a noncompartmental method. Following administration via inverted L nerve block, serum T(max) was 0.521 +/- 0.226 h and serum C(max) was 572 +/- 207 ng/mL. Serum AUC was 1348 +/- 335 ng.h/mL. Apparent serum t((1/2)beta) was 4.19 +/- 1.69 h and MRT was 5.13 +/- 2.33 h with clearance uncorrected for the extent of absorption of 2.75 +/- 0.68 L/kg/h. The last measurable time of lidocaine detection in serum was 8.5 +/- 1.4 h with a mean concentration of 51 +/- 30 ng/mL. Milk T(max) was detected at 1.75 +/- 0.46 h with C(max) of 300 +/- 139 ng/mL. Milk AUC till the last time was 1869 +/- 450 ng.h/mL with the mean AUC milk to AUC serum ratio of 1.439 +/- 0.374. The last measurable time of lidocaine detection in milk was 32.5 +/- 16.2 h with a mean concentration of 46 +/- 30 ng/mL. There was no detectable lidocaine concentration in any samples following caudal epidural administration.
- Published
- 2009
- Full Text
- View/download PDF
38. Normal reproductive capacity of heifers that originated from in vitro fertilized embryos cultured with an antiviral compound.
- Author
-
Givens MD, Marley MS, Riddell KP, Galik PK, and Stringfellow DA
- Subjects
- Animals, Antiviral Agents therapeutic use, Bovine Virus Diarrhea-Mucosal Disease drug therapy, Diarrhea Viruses, Bovine Viral, Efficiency drug effects, Embryo Culture Techniques veterinary, Embryo, Mammalian physiology, Embryo, Mammalian virology, Female, Fertilization in Vitro methods, Furans pharmacology, Furans therapeutic use, Imidazolines pharmacology, Imidazolines therapeutic use, Pregnancy, Pregnancy Rate, Prenatal Exposure Delayed Effects veterinary, Prenatal Exposure Delayed Effects virology, Reproduction physiology, Antiviral Agents pharmacology, Bovine Virus Diarrhea-Mucosal Disease embryology, Cattle embryology, Cattle physiology, Embryo, Mammalian drug effects, Prenatal Exposure Delayed Effects physiopathology, Reproduction drug effects
- Abstract
Bovine viral diarrhea virus (BVDV) can associate with in vitro fertilized (IVF) bovine embryos despite washing and trypsin treatment. An antiviral compound, DB606 (2-(4-[2-imidazolinyl]phenyl)-5-(4-methoxyphenyl)furan), inhibits the replication of BVDV in bovine uterine tubal epithelial cells, Madin Darby bovine kidney cells, and fetal fibroblast cells. As well, DB606 in in vitro culture medium does not affect embryonic development. Antiviral-treated-IVF embryos placed into recipients developed into clinically normal calves. The objective of this project was to determine if these resultant heifer calves were capable of reproducing. Seven heifers from each of the treatment groups (natural breeding, IVF embryo, and IVF embryo cultured in DB606) of the previous study were used. At 20-27 months of age, the heifers were exposed to a fertile bull in a single pasture during a 63 d breeding season. Five of the seven heifers originating from natural breeding were pregnant 35 d after removal of the bull and calved. All of the heifers resulting from transfer of untreated IVF embryos were pregnant at 35 d; however, one aborted the fetus at 5-7 months of gestation. All of the heifers derived from transfer of IVF embryos cultured in DB606 were pregnant and calved. Offspring from dams of all treatment groups were clinically normal at birth. Adjusted 205 d weaning weights were not significantly different among the offspring of the treated and untreated dams. These results indicate that culture of bovine-IVF embryos in DB606 does not impair future reproductive capacity of resulting heifers.
- Published
- 2009
- Full Text
- View/download PDF
39. Lactoferrin from bovine milk inhibits bovine herpesvirus 1 in cell culture but suppresses development of in vitro-produced bovine embryos.
- Author
-
Marley MS, Givens MD, Galik PK, Riddell KP, and Stringfellow DA
- Subjects
- Animals, Antiviral Agents administration & dosage, Cattle, Cells, Cultured, Cidofovir, Cytosine administration & dosage, Cytosine analogs & derivatives, Dose-Response Relationship, Drug, Drug Combinations, Drug Evaluation, Preclinical, Embryo Culture Techniques, Embryo, Mammalian, Female, Herpesviridae Infections prevention & control, Herpesvirus 1, Bovine physiology, Lactoferrin administration & dosage, Lactoferrin metabolism, Organophosphonates administration & dosage, Embryonic Development drug effects, Herpesvirus 1, Bovine drug effects, Lactoferrin pharmacology, Milk metabolism
- Abstract
Bovine herpesvirus 1 (BoHV-1) is widely distributed among cattle populations and has been associated with cells, fluids, and tissues collected from donor animals for use in reproductive technologies. The purpose of this study was to determine if lactoferrin would inhibit BoHV-1 in cell culture and to evaluate if embryos could develop normally when cultured in vitro with lactoferrin. In Experiment 1, lactoferrin (10 mg/mL) inhibited up to 25,000 plaque forming units (PFU)/mL of BoHV-1 in Madin Darby bovine kidney (MDBK) cell culture. In Experiment 2, lactoferrin (10 mg/mL) combined with cidofovir (62.5 microg/mL) inhibited up to 100,200 PFU/mL of virus in cell culture. In Experiment 3, following fertilization, presumptive zygotes were cultured in media containing lactoferrin (10, 5, and 2.5 mg/mL). Embryonic development and quality were assessed, and embryonic viability was determined by counting the nucleated cells of developed blastocysts. While lactoferrin did not affect the nucleated cell count of the treated embryos, it did significantly decrease blastocyst development. In conclusion, lactoferrin from bovine milk can inhibit BoHV-1 in cell culture. However, supplementation of in vitro culture medium with lactoferrin inhibits blastocyst development of in vitro-produced embryos.
- Published
- 2009
- Full Text
- View/download PDF
40. Amplification of bovine viral diarrhoea virus introduced into an in vitro embryo production system via oocytes from persistently infected cattle.
- Author
-
Marley MS, Givens MD, Galik PK, Riddell KP, and Stringfellow DA
- Subjects
- Animals, Culture Media, Embryo, Mammalian virology, Embryonic Development, Epithelial Cells physiology, Fallopian Tubes cytology, Female, Follicular Fluid virology, Oocytes growth & development, Cattle embryology, Diarrhea Viruses, Bovine Viral growth & development, Fertilization in Vitro veterinary, Oocytes virology
- Abstract
The purpose of this study was to determine whether or not embryos derived from in vitro fertilization of oocytes from persistently infected (PI) cattle would contain infectious virus.Three in vitro embryo production treatment groups were assessed: 1) oocytes and uterine tubal cells (UTC) free of bovine viral diarrhoea virus (BVDV) (negative control), 2)oocytes free of BVDV fertilized and cultured in media containing UTC obtained from PI heifers, and 3) oocytes from PI heifers fertilized and cultured in media containing UTC free of BVDV. The developmental media, UTC and embryos (individual or groups of five) were assayed for virus.Virus was not isolated from any samples in treatment group 1.As shown in previous studies, a proportion of embryo samples were positive for BVDV in treatment group 2. In treatment group 3, the virus associated with the oocytes contaminated the developmental media and infected susceptible co-culture cells used during fertilization and culture. In addition, 65% (11/17) of the degenerated ova from treatment group 3 had infectious virus associated with them. While none of the ova developed into transferable embryos, the study did confirm that use of oocytes from PI cows could lead to amplification of BVDV and cross contamination during in vitro embryo production.
- Published
- 2009
- Full Text
- View/download PDF
41. Bovine viral diarrhea virus (BVDV) associated with single in vivo-derived and in vitro-produced preimplantation bovine embryos following artificial exposure.
- Author
-
Gard JA, Givens MD, Marley MS, Galik PK, Riddell KP, Stringfellow DA, Zhang Y, and Edmondson MA
- Subjects
- Animals, Blastocyst pathology, Bovine Virus Diarrhea-Mucosal Disease complications, Cattle, Cells, Cultured, Cytopathogenic Effect, Viral physiology, DNA, Viral analysis, Embryo Culture Techniques, Female, Fertilization in Vitro, Pregnancy, Blastocyst virology, Bovine Virus Diarrhea-Mucosal Disease pathology, Diarrhea Virus 1, Bovine Viral genetics, Diarrhea Virus 1, Bovine Viral isolation & purification
- Abstract
The objective was to determine the average amount of bovine viral diarrhea virus (BVDV) associated with single in vivo-derived and in vitro-produced bovine embryos following recommended processing procedures for embryos. In vivo-derived and in vitro-produced bovine embryos at 7d post-fertilization were exposed (for 2h) to 2 x 10(5-7) cell culture infective dose (CCID(50))/mL of SD-1 (a noncytopathic, Type 1a strain of BVDV), and then washed according to International Embryo Transfer Society (IETS) guidelines prior to testing. Of the 87 in vivo-derived embryos tested, 27% were positive for virus by quantitative polymerase chain reaction (qPCR). The range in amount of virus associated with 99% of the contaminated embryos was
- Published
- 2009
- Full Text
- View/download PDF
42. Safety and efficacy of vaccination of seronegative bulls with modified-live, cytopathic bovine viral diarrhea viruses.
- Author
-
Givens MD, Riddell KP, Zhang Y, Galik P, Walz PH, Brodersen BW, Johnson JW, Passler T, Widel P, and Tremblay R
- Subjects
- Animals, Antigens, Viral analysis, Bovine Virus Diarrhea-Mucosal Disease prevention & control, Cattle, Cattle Diseases virology, Cytopathogenic Effect, Viral, Diarrhea Viruses, Bovine Viral isolation & purification, Diarrhea Viruses, Bovine Viral physiology, Immunohistochemistry, Male, RNA, Viral analysis, Reverse Transcriptase Polymerase Chain Reaction, Semen virology, Testicular Diseases pathology, Testicular Diseases veterinary, Testicular Diseases virology, Testis pathology, Testis virology, Viral Vaccines adverse effects, Viral Vaccines immunology, Diarrhea Viruses, Bovine Viral immunology, Vaccination veterinary
- Abstract
The objectives were to vaccinate peri-pubertal bulls with a modified-live vaccine consisting of cytopathic BVDV strains Singer and 296 and evaluate the resulting: (a) transient shed of modified-live, cytopathic BVDV in semen; (b) risk of prolonged testicular infection; and (c) protection against subsequent testicular infection due to viral challenge. Seronegative, peri-pubertal bulls were vaccinated subcutaneously with a standard dose of vaccine (n=11) or were maintained as unvaccinated controls (n=11). Forty-nine days after vaccination, all bulls were intranasally inoculated with a noncytopathic field strain of BVDV. Semen and testicular biopsies collected after vaccination and challenge were assayed for BVDV using virus isolation, reverse transcription-nested PCR, or immunohistochemistry, and the identity of viral strains was determined by nucleotide sequencing of PCR products. Vaccination of peri-pubertal bulls with this vaccine caused a short-term, transient shed of only the type 1a strain of modified-live, cytopathic BVDV in semen for up to 10d after vaccination. The vaccine did not cause prolonged testicular infection. Vaccination with this product prevented development of prolonged testicular infections after subsequent exposure to a field strain of BVDV.
- Published
- 2009
- Full Text
- View/download PDF
43. Tritrichomonas foetus infections in surveyed pet cats.
- Author
-
Stockdale HD, Givens MD, Dykstra CC, and Blagburn BL
- Subjects
- Aging, Animals, Antiprotozoal Agents therapeutic use, Cats, Feces parasitology, Female, Male, Protozoan Infections drug therapy, Protozoan Infections parasitology, United States, Cat Diseases parasitology, Protozoan Infections, Animal, Tritrichomonas foetus isolation & purification
- Abstract
Tritrichomonas foetus is the causative agent of feline trichomoniasis, a large-bowel disease resulting in chronic diarrhea. Feline trichomoniasis has been reported in cats of both pure and mixed breeds and in both males and females. In order to estimate the prevalence of trichomoniasis in the pet cat population, we requested fecal samples, via veterinarians throughout the United States, from cats with or without clinical signs of trichomoniasis. Of the 173 feline fecal samples received from veterinarians, 17 were culture and PCR positive for T. foetus. Our results suggested no correlation between breed or sex and infection with T. foetus. All cats that were infected with T. foetus had diarrhea at the time the fecal sample was taken. Other enteric pathogens were present in nine of the 17 positive cats. Our results support that trichomoniasis is a disease of younger male and female cats of all breeds.
- Published
- 2009
- Full Text
- View/download PDF
44. Bovine viral diarrhea virus is inactivated when whole milk from persistently infected cows is heated to prepare semen extender.
- Author
-
Marley MS, Tabor JM, Givens MD, Kaproth M, Riddell KP, Galik PK, Zhang Y, and Eason AB
- Subjects
- Animals, Cattle, Female, Male, Semen Preservation methods, Diarrhea Viruses, Bovine Viral physiology, Hot Temperature, Milk virology, Semen Preservation veterinary
- Abstract
Bovine viral diarrhea virus (BVDV) can be present in cryopreserved bovine semen and be transmitted through artificial insemination. Because BVDV can be shed in milk, the virus might also be introduced as a contaminant of milk-based semen extenders. Thus, the purpose of this study was to evaluate the epidemiologic risk of using heated, BVDV-contaminated milk to prepare semen extender. Milk was obtained from cows free of and persistently infected (PI) with BVDV. Six replicates of milk samples were processed by heating (85-92.2 degrees C, 10min). Samples of milk collected before and after heating were assayed for BVDV. Additionally, milk was injected intravenously into eight BVDV seronegative calves to monitor for seroconversion and viral infection. Virus was not detected in any milk samples from negative animals. Virus was consistently isolated from unheated milk samples from PI cows by passage of somatic cells, ultracentrifugation, and animal inoculation. Virus was usually detected in these samples by RT-nPCR (reverse transcription nested polymerase chain reaction). In heated milk samples from PI cows, no infectious BVDV was detected using any technique, but viral RNA was detected using RT-nPCR in four of six replicates. Bovine viral diarrhea virus in milk from PI cows was inactivated by heating. Therefore, properly heated milk used in semen extenders will not result in transmission of infectious BVDV. Although RT-nPCR detected the presence of viral RNA in milk samples after heating, the virus was not infectious as demonstrated by lack of replication despite using multiple sensitive techniques.
- Published
- 2009
- Full Text
- View/download PDF
45. Infectious causes of embryonic and fetal mortality.
- Author
-
Givens MD and Marley MS
- Subjects
- Animals, Female, Pregnancy, Abortion, Veterinary, Animals, Domestic microbiology, Pregnancy Complications, Infectious veterinary
- Abstract
The purpose of this review is to summarize bacterial, fungal, protozoan, and viral causes of reproductive dysgenesis in cattle, sheep, goats, pigs, horses, dogs, and cats. The clinical presentations of disease due to reproductive pathogens are emphasized, with a focus on assisting development of complete lists of causes that result in abortion and infertility in these species. Clinicians are encouraged to assess clinical presentation, create complete lists of differential diagnoses, obtain appropriate diagnostic samples, maximize diagnostic laboratory support, and avoid zoonotic infections resulting from reproductive pathogens of animals. The foundation of an accurate diagnosis of reproductive loss due to infectious pathogens facilitates the prudent use of immunization and biosecurity to minimize reproductive losses.
- Published
- 2008
- Full Text
- View/download PDF
46. Pathogens that cause infertility of bulls or transmission via semen.
- Author
-
Givens MD and Marley MS
- Subjects
- Animals, Cattle, Cattle Diseases transmission, Infertility, Male microbiology, Male, Semen, Cattle Diseases microbiology, Infertility, Male veterinary
- Abstract
The purpose of this paper is to review scientific evidence regarding pathogens that cause infertility of bulls or that could be transmitted via bovine semen. Although several pathogens can cause male infertility and potentially be transmitted via semen, adhering to disease control recommendations provided by Certified Semen Services (CSS) and the World Organization for Animal Health (OIE) can prevent infectious male infertility and ensure that the risk of pathogen transmission via semen is negligible. Regarding bulls to be used for natural breeding, quarantine prior to herd introduction and appropriate diagnostic testing during quarantine will commonly prevent introduction of pathogens that adversely affect reproduction.
- Published
- 2008
- Full Text
- View/download PDF
47. Development of a duplex quantitative polymerase chain reaction assay for detection of bovine herpesvirus 1 and bovine viral diarrhea virus in bovine follicular fluid.
- Author
-
Marley MS, Givens MD, Galik PK, Riddell KP, and Stringfellow DA
- Subjects
- Animals, Bovine Virus Diarrhea-Mucosal Disease virology, Cattle, Female, Infectious Bovine Rhinotracheitis virology, Diarrhea Viruses, Bovine Viral isolation & purification, Follicular Fluid virology, Herpesvirus 1, Bovine isolation & purification, Polymerase Chain Reaction veterinary
- Abstract
The objective of this study was to develop a duplex quantitative polymerase chain reaction (qPCR) assay for simultaneous detection of bovine herpesvirus 1 (BoHV-1) and bovine viral diarrhea virus (BVDV) type I and type II. Follicular fluid was collected from a BoHV-1 acutely infected heifer, a BVDV I persistently infected heifer, and from 10 ovaries recovered from an abattoir. Both the BoHV-1 and BVDV contaminated follicular fluid were diluted 1:5 to 1:10(7) using the pooled, abattoir-origin follicular fluid. Each dilution sample was analyzed using the duplex qPCR, virus isolation, reverse transcription-nested PCR (RT-nPCR), and BoHV-1 qPCR. The duplex qPCR was able to simultaneously detect BoHV-1 and BVDV I in the fluid diluted to 1:100 and 1:1000, respectively. These results corresponded with the reverse transcription-nested PCR and BoHV-1 qPCR. Therefore, the duplex qPCR might be used for quality assurance testing to identify these two viruses in cells, fluids and tissues collected from donor animals and used in reproductive technologies.
- Published
- 2008
- Full Text
- View/download PDF
48. Efficacy of a recombinant trypsin product against bovine herpesvirus 1 associated with in vivo- and in vitro-derived bovine embryos.
- Author
-
Marley MS, Givens MD, Galik PK, Riddell KP, Looney CR, and Stringfellow DA
- Subjects
- Animals, Cattle Diseases prevention & control, Cattle Diseases transmission, Embryo Transfer veterinary, Fertilization in Vitro veterinary, Herpesviridae Infections prevention & control, Herpesviridae Infections transmission, Herpesviridae Infections veterinary, Recombinant Proteins, Antiviral Agents pharmacology, Cattle embryology, Cattle Diseases virology, Embryo, Mammalian virology, Herpesvirus 1, Bovine drug effects, Trypsin pharmacology
- Abstract
Although porcine-origin trypsin will effectively remove bovine herpesvirus 1 (BHV-1) associated with in vivo-derived embryos, TrypLE, a recombinant trypsin-like protease, has not been evaluated. In Experiment 1, 17 groups of 10 in vivo-derived embryos were exposed to BHV-1, treated with TrypLE Express or TrypLE Select (10x concentration) for varying intervals, and assayed as 2 groups of 5 embryos. TrypLE Select treatment for 5 and 10 min (two and seven groups of five embryos, respectively) effectively inactivated BHV-1. In Experiment 2, 22 groups of 10 IVF embryos were treated and assayed. Treatment with TrypLE Select for 7 and 10 min (six groups of five embryos each) and with TrypLE Select diluted 1:2 for 10 min (seven groups of five embryos) was also effective. In Experiment 3, 17 groups of 10 IVF embryos were further evaluated with TrypLE Select undiluted and diluted 1:2 for 10 min. Treatment with the diluted product was effective (18 groups of five embryos), whereas the undiluted product was not completely effective (virus isolated from 2 of 16 groups). In Experiment 4, IVF embryos were treated as described in Experiment 3 and then cultured individually or as groups of five on uterine tubal cells (UTCs) for 48 h; 60% of UTC samples associated with groups of embryos and 35% of UTC associated with individual embryo samples were positive for BHV-1. Therefore, although TrypLE Select appeared to have promise for the treatment of in vivo-derived embryos, it cannot be recommended for treatment of in vitro-derived embryos.
- Published
- 2008
- Full Text
- View/download PDF
49. Sensitivity of polymerase chain reaction for detection of bovine viral diarrhea virus in pooled serum samples and use of pooled polymerase chain reaction to determine prevalence of bovine viral diarrhea virus in auction market cattle.
- Author
-
Smith RL, Sanderson MW, Walz PH, and Givens MD
- Subjects
- Animals, Blood Specimen Collection veterinary, Cattle, DNA, Viral chemistry, DNA, Viral genetics, Diarrhea Viruses, Bovine Viral genetics, Female, Midwestern United States epidemiology, Prevalence, Reverse Transcriptase Polymerase Chain Reaction methods, Sensitivity and Specificity, Bovine Virus Diarrhea-Mucosal Disease blood, Bovine Virus Diarrhea-Mucosal Disease virology, Diarrhea Viruses, Bovine Viral isolation & purification, Reverse Transcriptase Polymerase Chain Reaction veterinary
- Abstract
Two reverse transcription-nested polymerase chain reaction tests, 1 quantitative (qRT-nPCR) and 1 standard (RT-nPCR), were evaluated to assess sensitivity for detection of bovine viral diarrhea virus (BVDV) of a single positive serum sample in a pool of 30. The RT-nPCR and qRT-nPCR each detected 95 of 100 known positives. The RT-nPCR was used to estimate the prevalence of BVDV in adult beef cows. Serum samples were obtained from the US Department of Agriculture brucellosis testing laboratories in 3 Midwestern states. Samples originated from auction markets and private treaty sales throughout the 3 states. A total of 2,990 serum samples were collected and randomly pooled into 100 pools for testing. Two of the 100 pools of field samples were positive, and each positive pool had a single positive individual sample upon confirmation. The estimate of BVDV prevalence in adult cows in this study was 0.07%. This study estimates the diagnostic sensitivity of RT-nPCR for BVDV and confirms that it is a useful diagnostic tool for pools of 30 serum samples and that prevalence of BVDV in adult cattle from auction markets is low.
- Published
- 2008
- Full Text
- View/download PDF
50. Approaches to biosecurity in bovine embryo transfer programs.
- Author
-
Givens MD and Marley SD
- Subjects
- Animals, Cattle, Cattle Diseases microbiology, Cattle Diseases virology, Embryo Transfer methods, Embryo Transfer standards, Female, Male, Pregnancy, Risk Assessment, Cattle Diseases prevention & control, Embryo Transfer veterinary, Trypsin pharmacology
- Abstract
Although transfer of bovine embryos is much less likely to result in transmission of pathogens than transport of postnatal cattle, the epidemiologic risk associated with bovine embryo transfer merits examination. Much research has validated the efficacy of internationally approved processing protocols to render bovine in vivo-derived embryos free of specified pathogens. The purpose of this review is to summarize current sanitary recommendations for bovine embryo transfer, while emphasizing recent research to develop and validate novel approaches to biosecurity. Continued research will enable the development and validation of novel embryo treatments and culture reagents to minimize requirements for testing of embryo or oocyte donors, and testing of embryo recipients.
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.